Ponesimod 14 Day Pack
RxNorm 2532350

Concept Hierarchy & Relationship Mapping

RxNorm Concept Unique Identifier (RxCUI) 2532350 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: ponesimod 14 Day Pack.

The following semantic concepts and normalized strings are associated with this clinical entity:

PSN
Ponesimod 14 Day Pack
AUI:12618243
View
SY
Ponesimod 14 Day Pack
AUI:12618242
View
GPCK
{3 (ponesimod 10 mg Oral Tablet) / 2 (ponesimod 2 mg Oral Tablet) / 2 (ponesimod 3 mg Oral Tablet) / 2 (ponesimod 4 mg Oral Tablet) / 1 (ponesimod 5 mg Oral Tablet) / 1 (ponesimod 6 mg Oral Tablet) / 1 (ponesimod 7 mg Oral Tablet) / 1 (ponesimod 8 mg Oral Tablet) / 1 (ponesimod 9 mg Oral Tablet) } Pack
AUI:12618203
View

This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.

PSNPrescribable

Prescribable Name (PSN):
Ponesimod 14 Day Pack
(Atom ID: 12618243)

Clinical Status & Identity

Prescribable Status
YES (Active)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
ponesimod 14 Day Pack
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
2532350
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
12618243
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
PSN
Prescribable Name (Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.)
Source Code
2532350
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.
SYPrescribable

Synonym (SY):
Ponesimod 14 Day Pack
(Atom ID: 12618242)

Clinical Status & Identity

Prescribable Status
YES (Active)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
ponesimod 14 Day Pack
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
2532350
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
12618242
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
SY
Synonym (Synonym of another TTY, given for clarity.)
Source Code
2532350
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.
GPCKPrescribable

Generic Pack (GPCK):
{3 (ponesimod 10 mg Oral Tablet) / 2 (ponesimod 2 mg Oral Tablet) / 2 (ponesimod 3 mg Oral Tablet) / 2 (ponesimod 4 mg Oral Tablet) / 1 (ponesimod 5 mg Oral Tablet) / 1 (ponesimod 6 mg Oral Tablet) / 1 (ponesimod 7 mg Oral Tablet) / 1 (ponesimod 8 mg Oral Tablet) / 1 (ponesimod 9 mg Oral Tablet) } Pack
(Atom ID: 12618203)

Clinical Status & Identity

Prescribable Status
YES (Active)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
{3 (ponesimod 10 MG Oral Tablet) / 2 (ponesimod 2 MG Oral Tablet) / 2 (ponesimod 3 MG Oral Tablet) / 2 (ponesimod 4 MG Oral Tablet) / 1 (ponesimod 5 MG Oral Tablet) / 1 (ponesimod 6 MG Oral Tablet) / 1 (ponesimod 7 MG Oral Tablet) / 1 (ponesimod 8 MG Oral Tablet) / 1 (ponesimod 9 MG Oral Tablet) } Pack
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
2532350
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
12618203
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
GPCK
Generic Pack ({# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack)
Source Code
2532350
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.

Technical Attributes & Logic

RXN HUMAN DRUG
US
Drug available for use in Humans

Patient Education

Ponesimod


Ponesimod is used to prevent episodes of symptoms and slow the worsening of disability in adults who have relapsing forms of multiple sclerosis (MS; a disease in which the nerves do not function properly and people may experience weakness, numbness, loss of muscle coordination, and problems with vision, speech, and bladder control), including: clinically isolated syndrome (CIS; first nerve symptom episode that lasts at least 24 hours), relapsing-remitting disease (course of disease where symptoms flare up from time to time), active secondary progressive disease (later stage of disease with continuous worsening of symptoms.) Ponesimod is in a class of medications called sphingosine l-phosphate receptor modulators. It works by decreasing the action of immune cells that may cause nerve damage.
[Learn More]


* Please review the disclaimer below.